Yasmine Gabal

Yasmine Gabal, Ph.D., is a Scientist I at CSL, focusing on drug product development in R&D since February 2024. Prior to this role, Yasmine served as a Scientist at IMMORNA, where responsibilities included designing and optimizing mRNA loaded lipid nanoparticle formulations for CAR-T cell delivery and conducting various assays for characterization. From November 2020 to July 2023, Yasmine was an ORISE Fellow at the FDA’s CDER, contributing to regulatory review processes for generic drug products. Yasmine's academic background includes a Ph.D. in Chemical Engineering from Oklahoma State University and a Master’s in Pharmaceutics and Drug Delivery from Ain Shams University, where initial research involved solid lipid nanoparticles and drug delivery methods, alongside teaching pharmacy courses and conducting lab experiments.